Advertisement

Sepsis pp 124-136 | Cite as

Sepsis und Herzfunktion

  • M. M. Parker
  • J. E. Parrillo

Zusammenfassung

Die Sepsis und der septische Schock sind in eigentlich allen Gebieten der Medizin sehr bekannte Syndrome. Der septische Schock ist die Haupttodesursache auf Intensivstationen und ist mit einer Mortalität von annähernd 60% behaftet. Die Inzidenz der Sepsis ist in den letzten Jahren aufgrund der Zunahme invasiver medizinischer Techniken, einer aggressiven Chemotherapie und einer höheren Überlebensrate von Patienten, die für eine Sepsis prädisponiert sind, gestiegen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Calvin JE, Driedger AA, Sibbald WJ (1981) An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest 38: 579–586CrossRefGoogle Scholar
  2. 2.
    Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE (1986) The coronary circulation in human septic shock. Circulation 73: 637–644PubMedCrossRefGoogle Scholar
  3. 3.
    Danner RL, Elin RJ, Hosseini JM, et al. (1987) The effect of endotoxemia on the clinical manifestations of septic shock (SS) in humans. Clin Res 35: 384A (abstract)Google Scholar
  4. 4.
    Danner RL, Joiner KA, Parrillo JE (1987) Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X. J Clin Invest 80: 605–612PubMedCrossRefGoogle Scholar
  5. 5.
    Dhainaut JF, Huyghenbaert MF, Monsallier JF, et al. (1987) Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 75: 533–541PubMedCrossRefGoogle Scholar
  6. 6.
    Ellrodt AG, Riedinger MS, Kimchi A, et al. (1985) Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J 110: 402–408Google Scholar
  7. 7.
    Hinshaw LB, Archer LT, Spitzer JJ, et al. (1974) Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol 227: 1051–1057PubMedGoogle Scholar
  8. 8.
    Jacob HS, Craddock PR, Hammerschmidt DE, et al. (1980) Complement-induced granulocyte aggregation. N Engl J Med 302: 789–794PubMedCrossRefGoogle Scholar
  9. 9.
    Kimchi A, Ellrodt AG, Berman S, et al. (1984) Right heart ventricular performance in septic shock: a combined radionuclide and hemodynamic study. J Am Coll Cardiol 4: 945–951PubMedCrossRefGoogle Scholar
  10. 10.
    Krause SM, Hess ML (1979) Diphenhydramine protection of the failing myocardium during gram-negative endotoxemia. Circ Shock 6: 75–87PubMedGoogle Scholar
  11. 11.
    Lefer AM (1979) Mechanism of cardiodepression in endotoxin shock. Cire Shock [Suppl] 1: 1–8Google Scholar
  12. 12.
    MacLean LD, Mulligan WG, McLean APH, Duff JH (1967) Patterns of septic shock in man — a detailed study of 56 patients. Ann Surg 166: 543–562PubMedCrossRefGoogle Scholar
  13. 13.
    Mason JW, Kleeberg U, Dolan P, et al. (1970) Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann Intern Med 73: 545–551PubMedCrossRefGoogle Scholar
  14. 14.
    Natanson C, Fink MP, Ballantyne HK, et al. (1986) Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 78: 259–275PubMedCrossRefGoogle Scholar
  15. 15.
    Natanson C, Danner RL, Fink MP, et al. (1988) Cardiovascular performance with E. coli challenges in a canine model of human septic shock. Am J Physiol 23: H558 - H569Google Scholar
  16. 16.
    Nishijima H, Weil MH, Shubin H, Cavanilles J (1973) Hemodynamic and metabolic studies on shock associated with gram-negative bacteremia. Medicine 52: 287–294PubMedCrossRefGoogle Scholar
  17. 17.
    Ognibene FP, Parker MM, Burch-Whitman C, et al. (1988) Neutrophil aggregating activity and septic shock in humans. J Crit Care 3: 103–111CrossRefGoogle Scholar
  18. 18.
    Ozier Y, Gueret P, Jordin F, et al. (1984) Two-dimensional echocardiographic demonstration of acute myocardial depression in septic shock. Crit Care Med 12: 596–599PubMedCrossRefGoogle Scholar
  19. 19.
    Parker MM, Suffredini AF, Natanson C, et al. (1986) Survivors of septic shock in humans develop reversible myocardial depression and ventricular dilatation. Clin Res 34:413 A (abstract)Google Scholar
  20. 20.
    Parker MM, Shelhamer JH, Bachrach SL, et al. (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100: 483–490PubMedCrossRefGoogle Scholar
  21. 21.
    Parker MM, Shelhamer JH, Natanson C, Ailing DW, Parrillo JE (1987) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15: 923–929PubMedCrossRefGoogle Scholar
  22. 22.
    Parrillo JE, Burch C, Shelhamer JH, et al. (1985) A circulating myocardial depressant substance in humans with septic shock. J Clin Invest 76: 1539–1553PubMedCrossRefGoogle Scholar
  23. 23.
    Reilly JM, Burch-Whitman C, Parker MM, et al. (1987) Characteristics of a myocardial depressant substance in patients with septic shock. Circulation 76 (Part II): IV - 164 (abstract)Google Scholar
  24. 24.
    Schuette WH, Burch C, Roach P, Parrillo JE (1987) Closed loop television tracking of beating heart cells in vitro. Cytometry 8: 101–103PubMedCrossRefGoogle Scholar
  25. 25.
    Suffredini AF, Parker MM, Brenner M, Schlesinger T, Parrillo JE (1987) Endotoxin (E) administration produces abnormal cardiovascular (CV) responses in normal humans. Clin Res 35: 386A (abstract)Google Scholar
  26. 26.
    Vick JA, Mehlman B, Heiffer MH (1971) Early histamine release and death due to endotoxin (35690). Proc Soc Exp Biol Med 137: 902–906PubMedGoogle Scholar
  27. 27.
    Weil MH, MacLean LD, Visscher MB, Spink WW (1956) Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms. J Clin Invest 35: 1191–1198PubMedCrossRefGoogle Scholar
  28. 28.
    Weisel RD, Vito L, Dennis RC, Valerie CR, Hechtman HB (1977) Myocardial depression during sepsis. Am J Surg 133: 512–521PubMedCrossRefGoogle Scholar
  29. 29.
    Wiles JB, Cerra EB, Siegel JR, Border JR (1980) The systemic septic response: does the organism matter? Crit Care Med 8: 55–60PubMedCrossRefGoogle Scholar
  30. 30.
    Wilson RF, Thal AP, Kindling PH, Grillo. T, Ackerman E (1965) Hemodynamic measurements in septic shock. Arch Surg 91: 121–129CrossRefGoogle Scholar
  31. 31.
    Winslow EJ, Loeb HS, Rahimtoola SH, Kamath S, Gunnar RM (1973) Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 54: 421–432PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • M. M. Parker
  • J. E. Parrillo

There are no affiliations available

Personalised recommendations